Sartorius Stedim Biotech Launches ambr® 15 Bioreactor System with Nova BioProfile® FLEX2 Integration Unique system offers collection of massive quantities of cell culture data QbD studies in upstream processing more rapidly performed On show for the first time at Cell Line Development & Engineering in San Diego Goettingen, Germany — Sartorius Stedim Biotech (SSB), […]
MSK and ACEA will evaluate whether patient-specific ex-vivo cancer immunotherapy assays are predictive of in vivo efficacy. San Diego, CA ACEA Biosciences and Memorial Sloan Kettering Cancer Center (MSK) have entered into a collaboration to evaluate a personalized ex vivo potency assay using cancer patients’ malignant pleural effusions and ACEA’s xCELLigence Real-Time Cell Analysis (RTCA) […]
New Q Exactive HF-X Orbitrap mass spectrometer enables scientists to advance disease research and drug discovery INDIANAPOLIS – ASMS 2017 – Scientists studying complex protein samples can now take advantage of a new high-performing Orbitrap mass spectrometer designed to quickly and consistently produce superior data quality for challenging workflows across life science research and […]
LANSING, Mich. — Neogen Corporation (NASDAQ: NEOG) has expanded its comprehensive line of food allergen test kits to include a test for sesame that can be used to screen samples at a set level, or provide precise quantitative results. Neogen’s new Veratox® for Sesame Allergen test provides results in just 30 minutes after extraction. The new test can […]
INDIANAPOLIS — ASMS 2017 – Thermo Fisher Scientific Inc., the world leader in serving science, and BIOCRATES Life Sciences AG, a global leader in metabolic phenotyping, today launched a ready-to-use kit for accurate and confident metabolic phenotyping on high resolution mass spectrometry instruments. As part of a co-marketing agreement, the companies will jointly promote and market the combined […]
INDIANAPOLIS — ASMS 2017 – Thermo Fisher Scientific Inc., the world leader in serving science, today announced a co-marketing agreement with Biognosys AG, leader in next-generation proteomics, to provide a comprehensive, efficient workflow to enable library creation and data processing for Data-Independent Acquisition (DIA) studies, through the combined use of Orbitrap mass spectrometers and Spectronaut Pulsar software. […]
New proteins will advance research in testing and treating the West Nile Virus globally. New York — Enterprise Ireland, the Irish government agency for the promotion of international trade by Irish companies, today celebrated the success of client company Aalto Bio Reagents in launching its first-to-market native and recombinant West Nile virus (WNV) proteins for […]
NEW YORK and HILDEN, Germany – Bristol-Myers Squibb Company (NYSE: BMY) and QIAGEN(NASDAQ: QGEN; Frankfurt Prime Standard: QIA) have signed an agreement to explore the use of next-generation sequencing (NGS) technology to develop gene expression profiles (GEPs) as predictive or prognostic tools for use with Bristol-Myers Squibb novel immuno-oncology (I-O) therapies in cancer treatment. This will […]
Option to add new biomarkers for microsatellite instability (MSI) and mismatch repair (MMR) to QIAGEN’ s NGS panels Hilden, Germany, and Germantown, Maryland – QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received a worldwide license from The Johns Hopkins University for biomarkers that have been shown to play key roles in […]
Agreement Accelerates the Development of Tests to Help Assess Risk of Disease Recurrence in Women with Early-Stage Breast Cancer SANTA CLARA, Calif. & IRVINE, Calif.–Agilent Technologies Inc. (NYSE: A) and Agendia, Inc. today jointly announced an agreement to expand their relationship to include the development of an RNA-Seq kit version of Agendia’s currently marketed MammaPrint […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
